NCL statement on pause on J&J vaccine distribution
The decision for a momentary pause in distribution for the vaccine was enacted out of “an abundance of caution” on part of the CDC and FDA, following reports of 6 severe cases of a rare form of blood clots observed in young women, ranging from ages 18 to 48, roughly one to three weeks after receiving the shot.